Insights on Investing in VTR – What Our Analysts Know

By Blake Campbell • Friday, November 03 15:10 • Permanent Link

Ventas logged a 0.7% change during today's afternoon session, and is now trading at a price of $44.3 per share. The S&P 500 index moved 1.0%. VTR's trading volume is 1,768,635 compared to the stock's average volume of 2,320,284.

Ventas trades -11.41% away from its average analyst target price of $50.0 per share. The 17 analysts following the stock have set target prices ranging from $44.0 to $58.0, and on average have given Ventas a rating of buy.

Anyone interested in buying VTR should be aware of the facts below:

Ventas's current price is 331.7% above its Graham number of $10.26, which implies that at its current valuation it does not offer a margin of safety
Ventas has moved 13.0% over the last year, and the S&P 500 logged a change of 17.0%
Based on its trailing earnings per share of 0.22, Ventas has a trailing 12 month Price to Earnings (P/E) ratio of 201.3 while the S&P 500 average is None
VTR has a forward P/E ratio of 295.3 based on its forward 12 month price to earnings (EPS) of $0.15 per share
The company has a price to earnings growth (PEG) ratio of -7.08 — a number near or below 1 signifying that Ventas is fairly valued compared to its estimated growth potential
Its Price to Book (P/B) ratio is 1.82 compared to its sector average of None
Ventas Inc., an S&P 500 company, operates at the intersection of two large and dynamic industries healthcare and real estate.
Based in Chicago, the company has 451 full time employees and a market cap of $17.82 Billion. Ventas currently returns an annual dividend yield of 1.0%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.